GenMark's Q2 Revenues Grow 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic firm GenMark Diagnostics today reported revenue growth of 35 percent year over year for the second quarter as product revenue bounced 66 percent.

Total revenues rose to $901,000 for the three months ended June 30, compared to $665,000 a year ago. Product revenues grew to $866,000 during the quarter from $523,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.